Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Study to Compare IBB0979 in Combination With Topotecan Versus Topotecan in Subjects With Relapsed Small Cell Lung Cancer

NCT07076095 is registered in ClinicalTrials.gov with SUNHO（China）BioPharmaceutical CO., Ltd. as lead sponsor.

NCT NCT07076095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07076095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Study to Compare IBB0979 in Combination With Topotecan Versus Topotecan in Subjects With Relapsed Small Cell Lung Cancer
Lead sponsor
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
August 1, 2031
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer